Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances A Shepherd

Showing results (171-180 of 384) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancerMartin Früh, Estelle Rolland, Jean-Pierre Pignon, et al.
Lung Cancer (Amsterdam, Netherlands)|December 29, 2009
Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Andrea Ardizzoni, Jean-Yves Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancerDonald Bissett, Ken J O'Byrne, J von Pawel, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistanceGrainne M O'Kane, Geoffrey Liu, Tracy L Stockley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 23, 2009
The IASLC Lung Cancer Staging Project: data elements for the prospective projectDorothy J Giroux, Ramón Rami-Porta, Kari Chansky, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 23, 2009
Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin EvaluationJean-Yves Douillard, Hélène Tribodet, Delphine Aubert, et al.
Clinical Lung Cancer|December 24, 2014
Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinomaMeredith E Giuliani, Patricia E Lindsay, Jennifer Y Y Kwan, et al.
Journal of Proteome Research|September 7, 2010
Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signaturesYuhong Wei, Jiefei Tong, Paul Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the National Cancer Institute of Canada clinical trials groupScott A Laurie, Isabelle Gauthier, Andrew Arnold, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 17, 2012
A pooled exploratory analysis of the effect of tumor size and KRAS mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancerSinead Cuffe, Abderrahmane Bourredjem, Stephen Graziano, et al.
Pageof 39

Showing results (171-180 of 384) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancerMartin Früh, Estelle Rolland, Jean-Pierre Pignon, et al.
Lung Cancer (Amsterdam, Netherlands)|December 29, 2009
Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Andrea Ardizzoni, Jean-Yves Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancerDonald Bissett, Ken J O'Byrne, J von Pawel, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistanceGrainne M O'Kane, Geoffrey Liu, Tracy L Stockley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 23, 2009
The IASLC Lung Cancer Staging Project: data elements for the prospective projectDorothy J Giroux, Ramón Rami-Porta, Kari Chansky, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 23, 2009
Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin EvaluationJean-Yves Douillard, Hélène Tribodet, Delphine Aubert, et al.
Clinical Lung Cancer|December 24, 2014
Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinomaMeredith E Giuliani, Patricia E Lindsay, Jennifer Y Y Kwan, et al.
Journal of Proteome Research|September 7, 2010
Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signaturesYuhong Wei, Jiefei Tong, Paul Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the National Cancer Institute of Canada clinical trials groupScott A Laurie, Isabelle Gauthier, Andrew Arnold, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 17, 2012
A pooled exploratory analysis of the effect of tumor size and KRAS mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancerSinead Cuffe, Abderrahmane Bourredjem, Stephen Graziano, et al.
Pageof 39